AESGP picks Italy for next Annual Meeting
6 June 2019
The Association of the European Self-Medication Industry, the AESGP, has announced that its next Annual Meeting will be held in Italy.
Industry News
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
France reverse-switches RB's Strefen lozenges
Premium
4 June 2019
France has reverse-switched lozenges containing flurbiprofen from non-prescription to prescription status.
WSMI becomes Global Self-Care Federation
4 June 2019
The World Self-Medication Industry (WSMI) has changed its name to the Global Self-Care Federation. Alan Main, chair of the industry association, said the new name reflected a “fundamental change and shift in identity”.
Cranz returns as head of Germany's BAH
31 May 2019
Hubertus Cranz has been appointed director general of the German Medicines Manufacturers' Association, the BAH with effect from 31 May 2019.
ASMI is changing its name to CHP Australia
27 May 2019
The Australian Self Medication Industry (ASMI) is changing its name to Consumer Healthcare Products Australia (CHP Australia) with effect from 3 June 2019.
Daiichi Sankyo denies reports of OTC divestment
Premium
24 May 2019
Japan's Daiichi Sankyo has denied it is negotiating the sale of its OTC business.
Germany's Phoenix steps up digital offering
Premium
24 May 2019
Phoenix is launching a digital business unit called PXG Health Tech in summer 2019. The wholesaler and retailer said the aim was to offer customers across Europe digital solutions.
PAGB recruits Riddalls as senior director
24 May 2019
The Proprietary Association of Great Britain (PAGB) has appointed Michelle Riddalls as senior director of regulatory affairs and advertising services.
Ascendis terminates chief executive's contract
Premium
24 May 2019
Ascendis Health has "terminated" the contract of chief executive officer Thomas Thomsen with immediate effect.
German industry calls for rethink on switching
23 May 2019
Germany's procedure for switching medicines from prescription to non-prescription status is "outdated and should be modernised", according to the German Medicines Manufacturers' Association, the BAH.